Structured evidence table for Coenzyme Q10 Inflammation Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Coenzyme Q10 Inflammation Meta-Analysis | 1 2 3 4 4 5 Glycemic control has been associated with the development of several diseases. | 2 | Musazadeh Vali (2026) | Effects of Coenzyme Q10 Supplementation on Glycemic Control Biomarkers: An Umbrella Review of Meta‐Analyses of Randomised Controlled Trials |
| Coenzyme Q10 Inflammation Meta-Analysis | Evidence indicates that dysregulation of glucose metabolism makes individuals more susceptible to chronic diseases such as diabetes [], obesity [], dyslipidemia [], and cardiovascular diseases (CVD) []. | 2 | Musazadeh Vali (2026) | Effects of Coenzyme Q10 Supplementation on Glycemic Control Biomarkers: An Umbrella Review of Meta‐Analyses of Randomised Controlled Trials |
| Coenzyme Q10 Inflammation Meta-Analysis | Optimal blood sugar control, essential for diabetes management, involves maintaining glycosylated haemoglobin (A1C) levels below 7.0%, as levels exceeding this threshold are associated with a significantly increased risk of microvascular and cardiovascular complications [,]. | 2 | Musazadeh Vali (2026) | Effects of Coenzyme Q10 Supplementation on Glycemic Control Biomarkers: An Umbrella Review of Meta‐Analyses of Randomised Controlled Trials |
| Coenzyme Q10 Inflammation Meta-Analysis | Despite major advancements in pharmacotherapies and interventional cardiology, substantial residual risk persists among patients with established disease (). | 3 | Wu Xun (2026) | Advances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives |
| Coenzyme Q10 Inflammation Meta-Analysis | Additionally, many nutraceuticals are perceived to possess favorable safety and tolerability profiles compared to conventional medications, making them attractive for long-term risk reduction (). | 3 | Wu Xun (2026) | Advances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives |
| Coenzyme Q10 Inflammation Meta-Analysis | Banach et al., 2018 Cicero et al., 2017 Sesso et al., 2008 However, the field is marked by heterogeneous and sometimes contradictory evidence. | 3 | Wu Xun (2026) | Advances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives |
| Coenzyme Q10 Inflammation Meta-Analysis | Roth et al., 2020 Ganda et al., 2018 Visseren et al., 2021 Cardiovascular disease (CVD) is the leading cause of mortality worldwide, accounting for nearly one-third of global deaths each year (). | 3 | Wu Xun (2026) | Advances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives |
Source documents